Skip to main content


Inositol 1, 4, 5-trisphosphate receptor interacts with the SNARE domain of syntaxin 1B


Inositol 1, 4, 5-trisphosphate receptors (IP3Rs) are intracellular ligand-gated Ca2+ channels that mediate Ca2+ release from the endoplasmic reticulum (ER) into the cytosol and function in diverse cellular processes including fertilization, muscle contraction, apoptosis, secretion, and synaptic plasticity. The Ca2+ release activity of IP3Rs is tightly regulated by many factors including IP3R-binding proteins. We show that IP3Rs interact with syntaxin 1 (Syx1), a membrane trafficking protein that regulates various plasma-membrane ion channels including N-, P/Q, and L-type voltage-gated Ca2+ channels, voltage-gated potassium channels, and an epithelial sodium channel. We found that a SNARE-domain of Syx1B, one of the two Syx1 isoforms, directly interacted with the type1 IP3R (IP3R1) internal coupling domain, a known modulator for channel opening. These results indicate that Syx1B is an IP3R-interacting protein and that its interaction may play a crucial role in regulating the channel activity of IP3Rs in Syx1B-expressing cells.


The inositol 1, 4, 5-trisphosphate receptors (IP3Rs) are intracellular IP3-gated Ca2+ release channels on the endoplasmic reticulum (ER). They play a critical role in the initiation and propagation of the cytosolic free-Ca2+ concentration in response to various physiological stimuli [1, 2]. Three distinct genes encoding three subtypes of IP3Rs (types 1–3) have been identified in mammals [3, 4]. In the central nervous system, IP3R1 is predominantly expressed in brain tissue and plays a critical role in the regulation of synaptic plasticity [57]. IP3R1-knockout mice display motor control deficits including ataxia and seizure-like behavior [8]. The other two subtypes, types 2 and 3 IP3Rs (IP3R2 and IP3R3), are co-expressed in various tissues. Although IP3R2 and IP3R3 double-knockout mice do not exhibit ataxia, they show severe deficits in saliva, gastric juice secretion [9], and nasal mucus [10] secretions, suggesting that IP3R2 and IP3R3 are important for exocrine secretion [2].

Mouse IP3R1 is composed of 2,749 amino acids and consists of three domains (Fig. 1a): an N-terminal IP3-binding domain, a C-terminal domain, and an internal coupling domain connecting these two domains [11, 12]. The C-terminal domain has subdomains, a six-membrane-spanning channel pore-forming domain and a short cytoplasmic gatekeeper domain. The Ca2+ release activity of the IP3R channel is regulated by intracellular modulators (ATP, calmodulin, and Ca2+), protein kinases, and IP3R-binding proteins [2, 13], and the tight regulation of IP3R channel activity by these factors underlies the spatio-temporal intracellular Ca2+ dynamics required for diverse cellular processes [1420]. Therefore, further identification of IP3R-binding proteins is crucial for elucidating the molecular mechanism of regulation of IP3R-mediated Ca2+ dynamics and related cellular responses.

Fig. 1

Binding of Syx1B with IP3R1N-terminal cytosolic region. a A schematic representation of the domain structure of IP3R1 and its deletion mutant fused to GST (GST-EL). N-terminal IP3-binding domain (amino acids 1–579); the internal coupling domain (amino acids 580–2,217); the C-terminal domain (amino acids 2,218–2,749). The numbers refer to amino acids. b GST pull-down assays with mouse brain microsomal lysate. The microsomal lysate was incubated with GST or GST-EL, and the eluates from the Glutathione–Sepharose 4B beads were analyzed by immunoblotting with anti-Syx1B. Upper panel immunoblot using anti-Syx1B, lower panel amido black staining indicating GST and GST-EL proteins

Syntaxin 1 (Syx1) is a membrane trafficking protein that regulates secretory vesicle exocytosis [21]. Membrane trafficking is mediated by soluble N-ethylmaleimide-sensitive fusion protein (NSF) attachment protein receptors (SNAREs) [2224]. SNAREs were originally classified into two categories: vesicular SNAREs (v-SNAREs), which are localized in the donor membrane, and target SNAREs (t-SNAREs), which are localized in the acceptor compartment. The pairing of v- and t-SNAREs between two opposing membranes leads to the formation of a parallel alpha-helical bundle composed of four chains, called the SNARE complex, and subsequent membrane fusion [2528]. Syx1 is the most characterized t-SNARE and forms the SNARE complex with the t-SNARE protein SNAP25 and the v-SNARE protein VAMP2 [27]. In Ca2+-dependent exocytosis, Syx1 interacts with voltage-dependent Ca2+ channels (VDCCs), such as the N-, P/Q, and L-type Ca2+ channels [2932], and regulates their channel activity, which is required for rapid and precise Ca2+-dependent vesicle exocytosis [3335]. Furthermore, recent studies have shown that Syx1 interacts with and regulates other plasma membrane ion channels such as voltage-gated potassium channels (Kv1.1 and Kv2.1) [3638], an epithelial sodium channel (EnaC) [3941], and a cyclic AMP-gated chloride channel [cystic fibrosis transmembrane conductance regulator (CFTR)] [42]. Thus, it is generally accepted that Syx1 regulates various plasma-membrane ion channels. However, whether Syx1 regulates the intracellular ion channel IP3Rs remains to be elucidated. In the present study, to assess a potential Syx1 regulation of the intracellular ion channels, we investigated whether Syx1B binds to IP3Rs.

Materials and methods


All animal experiments were performed in accordance with the RIKEN guidelines.

Cell culture

A rat adrenal pheochromocytoma cell line, PC12, was maintained in Dulbecco’s modified Eagle’s essential medium (DMEM) supplemented with 10% fetal bovine serum, 10% horse serum, 100 U/ml penicillin, and 100 μg/ml streptomycin (Nacalai Tesque, Saitama, Japan). Cells were maintained at 37°C in 5% CO2.


A polyclonal antibody directed against Syntaxin1B (anti-Syx1B) was generated by immunizing rabbits with a synthetic Syx1B peptide (amino acid residues 171–187) fused with keyhole-limpet hemocyanin (KLH). The amino acid residues 171–187 of Syx1B were selected as the antigen. Other antibodies used in this study were goat anti-glutathione S-transferase (GST) antibody (GE Healthcare, Tokyo, Japan), rabbit anti-MBP antibody (New England Biolabs, Ipswich, MA, USA), mouse anti-IP3R1 antibody KM1112, mouse anti-IP3R2 antibody KM1083, and mouse anti-IP3R3 antibody KM1082 [43].

Plasmid construction

To generate the Baculovirus transfer vectors encoding GST-fused IP3R1 fragments, the GST-tag was cloned into the HindIII site of the pFastBac1 vector (designated pFB1-G). The enhanced green fluorescent protein (EGFP)-IP3R1/pcDNA3.1 zeo vector encoding full-length mouse IP3R1 [44] was used as a template to amplify the deletion mutants of IP3R1 by polymerase chain reaction (PCR) with the following oligonucleotides as primers. IP3R1 (1–343): sense, 5′-GCGGAATTCATGTCTGACAAAATGTCGAG-3′ and antisense, 5′-CGCGAATTCCCTACTCCGAGATGCATCCT-3′; IP3R1 (344–545): sense, 5′-GCGGAATTCTTGAGAAACGCGCAAGAAAA-3′ and antisense, 5′-CGCGAATTCGCGCTGATCCCCCAGCTCCT-3′; IP3R1 (546–750): sense, 5′-GCGGAATTCCATGCTCCTTTCAGACATAT-3′ and antisense, 5′-CGCGAATTCCAGGTACTGGCGGTCCAGAC-3′; IP3R1 (751–915): sense, 5′-GCGGAATTCGCCATCAATGAAATCTCCGG-3′ and antisense, 5′-CGCGAATTCAGACCTCATCACGTTACTGC-3′; IP3R1 (1,593–1,800): sense, 5′-GCGGAATTCTCCAGAGACTACCGAAATAT-3′ and antisense, 5′-CGCGAATTCTCACTTGTCGAGGTGACACTGAA-3′; IP3R1 (1,801–2,000): sense, 5′-GCGGAATTCGAGGGGGCCTCCAACCTGGT-3′ and antisense, 5′-CGCGAATTCTCAACACACCAAATTGTAGTTGG-3′; and IP3R1 (2,001–2,217): sense, 5′-GCGGAATTCGAGACACTGCAGTTTCTGGA-3′ and antisense, 5′-CGCGAATTCTCAGAATTCACAGATGCTGGGCA-3′. The fragments of IP3R1 (916–1,581) and IP3R1 (1,593–2,217) were obtained by digesting vectors GST-IIIab/pGEX4T-1 or GST-IV-Va/pGEX4T-1 [17] with EcoRI/SalI or EcoRI, respectively. These fragments were finally subcloned into pFB1-G.

The cDNA encoding mouse Syx1B (NCBI Accession ID; NM_024414) was amplified by PCR from a mouse hippocampus cDNA library using the following primers: sense, 5′-GCGGAATTCGATGAAGGATCGGACTCAG-3′ and antisense, 5′-CGCGAATTCCTACAAGCCCAGTGTCCC-3′. The resulting fragment was subcloned into mammalian expression vector pEGFP-C1 (Invitrogen, Tokyo, Japan) (designated EGFP-Syx1B). To generate the Escherichia coli expression vectors encoding the deletion mutants of Syx1B fused with maltose-binding protein (MBP) (designated MBP-Syx1B-Habc, MBP-Syx1B-SNARE, and MBP-Syx1B-dTMD), the Syx1B fragments were amplified by PCR using EGFP-Syx1B as a template, and the resulting fragments of Syx1B were subcloned into the EcoRI site of the pMAL-c plasmid. The following primers were used to amplify each Syx1B fragment. Syx1B-Habc: sense, 5′-CGGAATTCAAGGATCGGACTCAGGAGCT-3′ and antisense, 5′-CGGAATTCTCAGCGGTCCCGGTACTTGGAC-3′; Syx1B-SNARE: sense, 5′-CGGAATTCGATATCAAAATGGACTCGCA-3′ and antisense, 5′-GCGGAATTCTCAAATTTTCTTCCTCCTGGCCT-3′; and Syx1B-dTMD: sense, 5′-CGGAATTCAAGGATCGGACTCAGGAGCT-3′ and antisense, 5′-GCGGAATTCTCAAATTTTCTTCCTCCTGGCCT-3′.

Recombinant protein purification

GST-fused IP3R1 fragments were produced using the Sf9-Baculovirus overexpression system [17]. First, recombinant baculoviruses were generated using the pFB1-G plasmids described above with the Bac-to-Bac Baculovirus Expression System (Invitrogen). Sf9 cells were infected with the resultant baculoviruses, and the proteins produced were purified using glutathione–Sepharose 4B (GE Healthcare). MBP-fused Syx1B deletion mutants were expressed in E. coli JM109 and purified using amylose resin (New England Biolabs). Purified proteins were dialyzed using a cytosol-like medium [CLM; 50 mM HEPES–KOH (pH 7.2), 110 mM KCl, 10 mM NaCl, 5 mM KH2PO4, and 1 mM 2-mercaptoethanol]. Concentrations of purified recombinant proteins were measured with a Protein Assay Kit (BioRad, Tokyo, Japan) using bovine serum albumin (BSA) as a standard.

Subcellular fractionation

Adult brain tissues were isolated from postnatal day 56 ICR mice and were homogenized in homogenization buffer [0.32 M sucrose, 5 mM HEPES–KOH (pH 7.4), 100 μM PMSF, and a Complete Protease Inhibitor Cocktail Tablet (EDTA-free) (Roche, Tokyo, Japan)] by a glass-Teflon homogenizer. Homogenates were centrifuged at 800g for 10 min at 4°C, and the resulting supernatants were centrifuged at 100,000g for 1 h at 4°C. The pellet was collected as the crude microsomal fraction.

Binding experiments

For the pull-down assays, microsomal fractions were solubilized in pull-down buffer [20 mM Tris–HCl (pH 7.4), 100 mM NaCl, 2 mM Na3VO4, 10 mM NaF, 2 mM EGTA, 0.5% Triton-X100, and a Complete Protease Inhibitor Cocktail Tablet (EDTA-free) (Roche)] for 2 h at 4°C. The insoluble fraction was precipitated by centrifugation at 20,400g for 15 min at 4°C. The supernatant was incubated with 40 μl of 50% glutathione–Sepharose 4B bead slurry for 2 h at 4°C. The mixture was centrifuged at 1,500g for 20 s at 4°C, and the supernatant was used as the precleared microsomal lysate. Recombinant GST-fused IP3R1 fragments or MBP-Syx1B fragments (3.8 × 10−10 mol, an equal amount to 10 μg GST) were diluted in 1 ml of CLM and incubated with glutathione–Sepharose 4B or amylose resin beads for 1–2 h at 4°C. Beads were washed three times with pull-down buffer and mixed with the precleared microsomal lysate, and this mixture was agitated by a rotary shaker for 1–2 h at 4°C. The beads were washed 3 times with pull-down buffer, and the bound proteins were analyzed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting.

In the direct binding assay, 3.8 × 10−10 mol of GST-fused IP3R1 fragments and MBP-fused Syx1B fragments were incubated in CLM containing 1% TritonX-100 for 12 h at 4°C, followed by incubation for another 2 h at 4°C after the addition of 20 μL of a 50% suspension of amylose resin beads (New England Biolabs). The bound proteins were analyzed by SDS-PAGE and immunoblotting as described above.

For immunoprecipitation experiments, crude microsomal fractions were solubilized in lysis buffer A [20 mM Tris–HCl (pH 7.0), 100 mM NaCl, 2 mM Na3VO4, 10 mM NaF, 1% TritonX-100, and a Complete Protease Inhibitor Cocktail Tablet (EDTA-free) (Roche)] for 1–2 h at 4°C. The homogenate was centrifuged at 20,400g for 15 min at 4°C to remove the insoluble fraction. The supernatant was diluted using a dilution buffer [20 mM Tris–HCl (pH 7.0), 100 mM NaCl, 2 mM Na3VO4, 10 mM NaF, and a Complete Protease Inhibitor Cocktail Tablet (EDTA-free) (Roche)] to lower the TritonX-100 concentration to 0.5% and was then precleared with Protein G-Sepharose 4 Fast Flow (GE Healthcare) for 1–2 h at 4°C.

For immunoprecipitation using whole-cell lysate, the cells were first suspended in Lysis buffer B [20 mM HEPES–NaOH (pH 7.4), 100 mM NaCl, 2 mM EGTA, 0.1% TritonX-100, and a Complete Protease Inhibitor Cocktail Tablet (EDTA-free)] and solubilized by mild agitation for 1–2 h at 4°C. The cell lysates were then homogenized by 10 passages through a 27-gauge needle and centrifuged at 20,000g for 30 min at 4°C to remove the insoluble fraction. The supernatant was precleared by the addition of Protein G-Sepharose 4 Fast Flow (GE Healthcare), incubated with rabbit normal IgG (Chemicon, Temecula, CA, USA) or polyclonal anti-Syx1B antibody for 1–2 h at 4°C, and incubated with Protein G-Sepharose 4 Fast Flow beads for 1 h at 4°C. After washing the beads 3 times with IP buffer [20 mM Tris–HCl (pH 7.0), 100 mM NaCl, 2 mM Na3VO4, 10 mM NaF, 0.5% TritonX-100, a Complete Protease Inhibitor Cocktail Tablet (EDTA-free) (Roche)] or lysis buffer B, the bound proteins were analyzed by SDS-PAGE and immunoblotting.


Proteins were separated by SDS-PAGE and transferred to polyvinylidene fluoride (PVDF) membrane (Millipore, Bedford, MA, USA) by electroblotting. The membrane was blocked with 5% skim milk for 1 h at room temperature and then incubated with primary antibody diluted in 5% skim milk at the appropriate dilution (anti-Syx1B, 1: 2000; KM1112, 1:1,000; KM1083, 1:1,000; KM1082, 1:1,000; anti-GST (GE Healthcare), 1:2,000; and anti-MBP (New England Biolabs), 1:3,000) for 2–3 h at room temperature. After washing 3 times with PBS containing 0.1% Tween 20 (PBS-T), the membrane was incubated with secondary antibody conjugated with horseradish peroxidase (Jackson ImmunoResearch, West Grove, PA, USA) for 1 h at room temperature or overnight at 4°C. After washing 3 times with PBS-T, immunoreactive protein bands were detected with chemiluminescence using ECL or ECL Plus (GE Healthcare).

Coiled-coil prediction

Amino acid sequences were analyzed using the second structure prediction program which was developed by Lupas et al. [45]. The window size chosen was 21.


IP3Rs consist of an N-terminal IP3-binding domain, an internal coupling domain, a C-terminal domain including a six-membrane spanning channel pore-forming subdomain, and a C-terminal gatekeeper subdomain [11, 12] (Fig. 1a). To investigate the interaction of IP3Rs with Syx1B, we first performed a GST pull-down assay using mouse brain microsomal lysate and recombinant GST-EL containing the long N-terminal cytosolic region (amino acid residues 1–2,217) of IP3R1 [16] (Fig. 1a). Syx1B co-precipitated with GST-EL but not with GST alone (Fig. 1b). We further explored the Syx1B-binding site in the N-terminal region of IP3R1 using various GST-fused IP3R1 deletion mutants (Fig. 2) and found that Syx1B co-precipitated with GST-fused mutants containing amino acid residues 1,593–2,217 of IP3R1 (Fig. 2b, lanes 4, 5). We next used three GST-fused IP3R1 mutants containing amino acid residues 1,593–1,800, 1,801–2,000, or 2,001–2,217 and found that Syx1B specifically co-precipitated with GST-fused mutant 1,593–1,800 (Fig. 2c, lane 2). Syx1 possesses a single C-terminal transmembrane domain (TMD, amino acid residues 266–288), a SNARE domain (known as H3, amino acid residues 189–265), an N-terminal regulatory domain (Habc, amino acid residues 1–143), and a linker region (amino acid residues 144–188) connecting the SNARE and Habc domains [46] (Fig. 3a). We prepared three MBP-fused Syx1B mutants containing amino acid residues 1–143 (Habc), 179–265 (SNARE), or 1–265 (dTMD). To investigate the IP3R1-binding region in Syx1B, we performed the MBP pull-down assay using mouse brain lysate and MBP-fused Syx1B deletion mutants (Fig. 3a). IP3R1 co-precipitated with MBP-Syx1B-SNARE but not with MBP alone (Fig. 3b). IP3R1 that co-precipitated with MBP-Syx1B-dTMD was weakly detected by immunoblotting after a long exposure (Fig. 3b). To test if this interaction occurs between purified proteins, we performed the MBP pull-down assay with purified GST-IP3R (1,593–2,217) and MBP-fused Syx1B-deletion mutants. GST-IP3R (1,593–2,217) co-precipitated with MBP-Syx1B-SNARE and -dTMD, but not with MBP alone (Fig. 4a). We next tested the interaction between GST-IP3R (1,593–1,800) and MBP-fused Syx1B mutants. As a result, GST-IP3R (1,593–1,800) was also co-precipitated with MBP-Syx1B-SNARE and -dTMD (Fig. 4b). These results indicated that Syx1B directly interacts with IP3R1. Next, we examined whether Syx1B binds to IP3R1 in vivo. Immunoprecipitation experiments using anti-Syx1B demonstrated that brain IP3R1 co-immunoprecipitated with Syx1B (Fig. 5). The protein sequence of mouse IP3R1 is highly homologous to that of mouse IP3R2 (approximately 70.9% identity) and IP3R3 (approximately 65.2% identity) [4]. As expected, we found that IP3R2 and IP3R3 co-immunoprecipitated with Syx1B (Fig. 5), suggesting that all IP3R isoforms form a complex with Syx1B. PC12 cells express IP3R1, IP3R3 [4749], and Syx1B [50]. We performed an immunoprecipitation assay to examine whether endogenous IP3Rs interact with Syx1B in PC12 cells. Both IP3R1 and IP3R3 co-immunoprecipitated with Syx1B (Fig. 6), indicating that Syx1B interacts with IP3R1 and IP3R3 in PC12 cells.

Fig. 2

Identification of the Syx1B-binding region in IP3R1. a Schematic representation of GST-fused IP3R1 deletion mutants. The various regions of the IP3R1 were prepared as GST fusion proteins. The numbers refer to amino acids. b, c GST pull-down assays with mouse brain microsomal lysate. The microsomal lysate was incubated with each GST-fusion proteins immobilized on Glutathione–Sepharose 4B beads, and the bound proteins were analyzed by immunoblotting with anti-Syx1B. Upper panels in (b, c) immunoblot using anti-Syx1B; lower panels in (b, c) amido black staining indicating GST and GST-fused IP3R1 deletion mutants

Fig. 3

Identification of IP3R1-binding region in Syx1B. a Schematic representation of the domain structure of Syx1B and its deletion mutants fused to MBP. N-terminal regulatory domain (Habc, amino acids 1–143), the linker region (amino acids 144–188), the SNARE domain (amino acids 189–265), and the single C-terminal transmembrane domain (TMD, amino acid residues 266–288). The numbers refer to amino acids. b MBP pull-down assays with mouse brain microsomal lysate. The microsomal lysate was incubated with MBP or MBP-fused Syx1B deletion mutants, and the eluates from the amylose resin beads were analyzed by immunoblotting with anti-IP3R1. Immunoblots with short exposure (upper panel) and long exposure (middle panel) using anti-IP3R1, lower panel immunoblot using anti-MBP to detect MBP and MBP-fused Syx1B deletion mutants

Fig. 4

Direct binding of IP3R1 with Syx1B. a, b Indicated recombinant GST-IP3R1 mutants were incubated with the indicated MBP-Syx1B mutants, and the eluates from the amylose resin beads were analyzed by immunoblotting with anti-GST antibody (upper panel) or with anti-MBP antibody (lower panel)

Fig. 5

IP3R1 binds with Syx1B in vivo. Immunoprecipitation of endogenous proteins from mouse brain microsomal lysate using anti-Syx1B. The precipitates were analyzed by western blotting using anti-Syx1B, anti-IP3R1 (KM1112), IP3R2 (KM1083), and IP3R3 (KM1082) isoform specific antibodies

Fig. 6

IP3R1 binds to Syx1B in neuroendocrine cell line PC12. Whole cell lysates were subjected to immunoprecipitation by anti-Syx1B. The precipitates were analyzed by western blotting using anti-Syx1B, anti-IP3R1 (KM1112), and anti-IP3R3 (KM1082) antibodies

These results suggested the existence of common structural feature of Syx1B-binding region among all IP3Rs. We found the predicted coiled-coil domain in the first 28 amino acids of Syx1B-binding region of IP3R1 (Fig. 7). In addition, this predicted coiled coil domain in this region was conserved both in IP3R2 and in IP3R3 (Fig. 7).

Fig. 7

Predicted coiled coil domain in Syx1B-binding region of IP3Rs. Probability of coiled-coil domains for the whole length of the N-terminal cytoplasmic region of each IP3Rs was predicted using the method developed by Lupas et al. [45]. The numbers indicated are amino acid residues of each IP3Rs


Syx1 binds to plasma membrane ion channels directly and regulates their channel activity [3443]. In the present study, we demonstrated for the first time that Syx1B binds to internal Ca2+ channel IP3Rs. The Syx1B-binding site was located within amino acid residues 1,593–1,800 of the internal coupling domain of IP3R1 (Fig. 3). Many IP3R-binding proteins have been isolated [1618, 20, 51], but no reports have described binding proteins that demonstrate specific interaction with amino acid residues 1,593–1,800 of IP3R1. Although this region of IP3R1 is not highly conserved in IP3R2 (approximately 41.8% identity) and IP3R3 (approximately 39.9% identity), the first 28 amino acid residues of this region in all IP3Rs were predicted to form the coiled-coil structure (Fig. 7), which has been generally recognized as an important domain for protein–protein interaction [45]. In addition, the first 28 amino acid residues of IP3R1 are highly conserved in IP3R2 (approximately 57.1% identity) and IP3R3 (approximately 71.4% identity) [4]. Because Syx1B can interact with all IP3Rs (Fig. 5), these results suggest that the amino acid residues (1,593–1,620) of IP3R1 are important for specific binding with Syx1B. We previously showed that inhibition of IP3R1 channel opening by a high concentration of Ca2+ is mediated by calmodulin (CaM) in vitro [14, 15]. CaM associates with amino acid residues 1,564–1,585 of IP3R1 [52, 53], which are located just upstream of the region of the Syx1B-binding site that we found in this study. Thus, the further investigation of the relationship between Ca2/CaM-dependent channel inhibition and Syx1B-binding is of interest.

The SNARE domain of Syx1 reportedly binds to both SNAP25 and VAMP2 to form the SNARE complex, which is believed to drive the fusion of the vesicle and plasma membranes [54]. In addition, the SNARE domain of Syx1 interacts with VDCCs, resulting in the formation of the “Ca2+ microdomain” required for coupling depolarization-dependent Ca2+ influx to trigger exocytosis [55]. Previous studies reported that anti-Syx1 antibody, which reacted against Syx1A and Syx1B, raised immunoreactive signals mainly on the plasma membrane and synaptic vesicles of presynaptic terminals around the dendrites of Purkinje cells [56, 57]. In addition, another study suggested that Syx1B, not Syx1A is predominant isoforms expressed in cerebellum [58] These reports suggested that Syx1B is localized predominantly on the plasma membrane and synaptic vesicles, although a small amount is localized on ER, nuclear membranes in granule cells [56]. We showed that the SNARE domain of Syx1B interacts with IP3Rs (Figs. 3, 4). These findings raise the possibility that the Stx1B-IP3Rs complex makes a bridge between the ER and plasma membranes, resulting in the formation of the Ca2+ microdomain required for coupling IP3-induced Ca2+ release to trigger exocytosis. In fact, IP3-induced Ca2+ release from IP3R1 is known to trigger dopamine secretion in response to bradykinin in neuroendocrine PC12 cells [49], where IP3R1 and IP3R3 were found to interact with Syx1B (Fig. 6). Whether IP3Rs interacts with the SNARE complex to form the Ca2+ micro-domain remains to be determined in a future study. We have previously shown that enhanced paired-pulse facilitation and enhanced post-tetanic potentiation are observed in the hippocampus of IP3R1-knockout mice [7, 59], suggesting that the presynaptic neurotransmitter mechanism is altered by the absence of IP3R1. Further studies that focus on the IP3Rs, Syx1B, and the SNARE complex may accelerate our understanding of the molecular mechanism underlying IP3R-mediated synaptic plasticity.


  1. 1.

    Mikoshiba K (2007) The IP3 receptor/Ca2+ channel and its cellular function. Biochem Soc Symp (7):9–22

  2. 2.

    Mikoshiba K (2008) From Ca2+ in muscle contraction to IP3 receptor/Ca2+ signaling In memory of Setsuro Ebashi. Biochem Biophys Res Commun 369:57–61

  3. 3.

    Furuichi T, Yoshikawa S, Miyawaki A, Wada K, Maeda N, Mikoshiba K (1989) Primary structure and functional expression of the inositol 1, 4, 5-trisphosphate-binding protein P400. Nature 342:32–38

  4. 4.

    Iwai M, Tateishi Y, Hattori M, Mizutani A, Nakamura T, Futatsugi A, Inoue T, Furuichi T, Michikawa T, Mikoshiba K (2005) Molecular cloning of mouse type 2 and type 3 inositol 1, 4, 5-trisphosphate receptors and identification of a novel type 2 receptor splice variant. J Biol Chem 280:10305–10317

  5. 5.

    Itoh S, Ito K, Fujii S, Kaneko K, Kato K, Mikoshiba K, Kato H (2001) Neuronal plasticity in hippocampal mossy fiber-CA3 synapses of mice lacking the inositol-1, 4, 5-trisphosphate type 1 receptor. Brain Res 901:237–246

  6. 6.

    Inoue T, Kato K, Kohda K, Mikoshiba K (1998) Type 1 inositol 1, 4, 5-trisphosphate receptor is required for induction of long-term depression in cerebellar Purkinje neurons. J Neurosci 18:5366–5373

  7. 7.

    Nagase T, Ito KI, Kato K, Kaneko K, Kohda K, Matsumoto M, Hoshino A, Inoue T, Fujii S, Kato H, Mikoshiba K (2003) Long-term potentiation and long-term depression in hippocampal CA1 neurons of mice lacking the IP(3) type 1 receptor. Neuroscience 117:821–830

  8. 8.

    Matsumoto M, Nakagawa T, Inoue T, Nagata E, Tanaka K, Takano H, Minowa O, Kuno J, Sakakibara S, Yamada M, Yoneshima H, Miyawaki A, Fukuuchi Y, Furuichi T, Okano H, Mikoshiba K, Noda T (1996) Ataxia and epileptic seizures in mice lacking type 1 inositol 1, 4, 5-trisphosphate receptor. Nature 379:168–171

  9. 9.

    Futatsugi A, Nakamura T, Yamada MK, Ebisui E, Nakamura K, Uchida K, Kitaguchi T, Takahashi-Iwanaga H, Noda T, Aruga J, Mikoshiba K (2005) IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism. Science 309:2232–2234

  10. 10.

    Fukuda N, Shirasu M, Sato K, Ebisui E, Touhara K, Mikoshiba K (2008) Decreased olfactory mucus secretion and nasal abnormality in mice lacking type 2 and type 3 IP3 receptors. Eur J Neurosci 27:2665–2675

  11. 11.

    Mignery GA, Newton CL, Archer BT 3rd, Sudhof TC (1990) Structure and expression of the rat inositol 1, 4, 5-trisphosphate receptor. J Biol Chem 265:12679–12685

  12. 12.

    Miyawaki A, Furuichi T, Ryou Y, Yoshikawa S, Nakagawa T, Saitoh T, Mikoshiba K (1991) Structure-function relationships of the mouse inositol 1, 4, 5-trisphosphate receptor. Proc Natl Acad Sci USA 88:4911–4915

  13. 13.

    Foskett JK, White C, Cheung KH, Mak DO (2007) Inositol trisphosphate receptor Ca2+ release channels. Physiol Rev 87:593–658

  14. 14.

    Hirota J, Michikawa T, Natsume T, Furuichi T, Mikoshiba K (1999) Calmodulin inhibits inositol 1, 4, 5-trisphosphate-induced calcium release through the purified and reconstituted inositol 1, 4, 5-trisphosphate receptor type 1. FEBS Lett 456:322–326

  15. 15.

    Michikawa T, Hirota J, Kawano S, Hiraoka M, Yamada M, Furuichi T, Mikoshiba K (1999) Calmodulin mediates calcium-dependent inactivation of the cerebellar type 1 inositol 1, 4, 5-trisphosphate receptor. Neuron 23:799–808

  16. 16.

    Ando H, Mizutani A, Matsu-ura T, Mikoshiba K (2003) IRBIT, a novel inositol 1, 4, 5-trisphosphate (IP3) receptor-binding protein, is released from the IP3 receptor upon IP3 binding to the receptor. J Biol Chem 278:10602–10612

  17. 17.

    Ando H, Mizutani A, Kiefer H, Tsuzurugi D, Michikawa T, Mikoshiba K (2006) IRBIT suppresses IP3 receptor activity by competing with IP3 for the common binding site on the IP3 receptor. Mol Cell 22:795–806

  18. 18.

    Zhang S, Hisatsune C, Matsu-Ura T, Mikoshiba K (2009) G-protein-coupled receptor kinase-interacting proteins inhibit apoptosis by inositol 1, 4, 5-triphosphate receptor-mediated Ca2+ signal regulation. J Biol Chem 284:29158–29169

  19. 19.

    Higo T, Hamada K, Hisatsune C, Nukina N, Hashikawa T, Hattori M, Nakamura T, Mikoshiba K (2010) Mechanism of ER stress-induced brain damage by IP(3) receptor. Neuron 68:865–878

  20. 20.

    Higo T, Hattori M, Nakamura T, Natsume T, Michikawa T, Mikoshiba K (2005) Subtype-specific and ER lumenal environment-dependent regulation of inositol 1, 4, 5-trisphosphate receptor type 1 by ERp44. Cell 120:85–98

  21. 21.

    Wojcik SM, Brose N (2007) Regulation of membrane fusion in synaptic excitation-secretion coupling: speed and accuracy matter. Neuron 55:11–24

  22. 22.

    Sollner T, Whitehart SW, Brunner M, Erdjumentbromage H, Geromanos S, Tempst P, Rothman JE (1993) Snap receptors implicated in vesicle targeting and fusion. Nature 362:318–324

  23. 23.

    Rothman JE, Warren G (1994) Implications of the SNARE hypothesis for intracellular membrane topology and dynamics. Curr Biol 4:220–233

  24. 24.

    Rizo J, Rosenmund C (2008) Synaptic vesicle fusion. Nat Struct Mol Biol 15:665–674

  25. 25.

    Fiebig KM, Rice LM, Pollock E, Brunger AT (1999) Folding intermediates of SNARE complex assembly. Nat Struct Biol 6:117–123

  26. 26.

    Parlati F, McNew JA, Fukuda R, Miller R, Sollner TH, Rothman JE (2000) Topological restriction of SNARE-dependent membrane fusion. Nature 407:194–198

  27. 27.

    Chen YA, Scales SJ, Scheller RH (2001) Sequential SNARE assembly underlies priming and triggering of exocytosis. Neuron 30:161–170

  28. 28.

    Melia TJ, Weber T, McNew JA, Fisher LE, Johnston RJ, Parlati F, Mahal LK, Sollner TH, Rothman JE (2002) Regulation of membrane fusion by the membrane-proximal coil of the t-SNARE during zippering of SNAREpins. J Cell Biol 158:929–940

  29. 29.

    Sheng ZH, Rettig J, Takahashi M, Catterall WA (1994) Identification of a syntaxin-binding site on N-type calcium channels. Neuron 13:1303–1313

  30. 30.

    MartinMoutot N, Charvin N, Leveque C, Sato K, Nishiki T, Kozaki S, Takahashi M, Seagar M (1996) Interaction of SNARE complexes with P/Q-type calcium channels in rat cerebellar synaptosomes. J Biol Chem 271:6567–6570

  31. 31.

    Rettig J, Sheng ZH, Kim DK, Hodson CD, Snutch TP, Catterall WA (1996) Isoform-specific interaction of the alpha(1A) subunits of brain Ca2+ channels with the presynaptic proteins syntaxin and SNAP-25. Proc Natl Acad Sci USA 93:7363–7368

  32. 32.

    Yang SN, Larsson O, Branstrom R, Bertorello AM, Leibiger B, Leibiger IB, Moede T, Kohler M, Meister B, Berggren PO (1999) Syntaxin 1 interacts with the L-D subtype of voltage-gated Ca2+ channels in pancreatic beta cells. Proc Natl Acad Sci USA 96:10164–10169

  33. 33.

    Bezprozvanny I, Scheller RH, Tsien RW (1995) Functional impact of syntaxin on gating of N-type and Q-type calcium channels. Nature 378:623–626

  34. 34.

    Wiser O, Bennett MK, Atlas D (1996) Functional interaction of syntaxin and SNAP-25 with voltage-sensitive L- and N-type Ca2+ channels. EMBO J 15:4100–4110

  35. 35.

    Kang Y, Huang X, Pasyk EA, Ji J, Holz GG, Wheeler MB, Tsushima RG, Gaisano HY (2002) Syntaxin-3 and syntaxin-1A inhibit L-type calcium channel activity, insulin biosynthesis and exocytosis in beta-cell lines. Diabetologia 45:231–241

  36. 36.

    Fili O, Michaelevski I, Bledi Y, Chikvashvili D, Singer-Lahat D, Boshwitz H, Linial M, Lotan I (2001) Direct interaction of a brain voltage-gated K+ channel with syntaxin 1A: functional impact on channel gating. J Neurosci 21:1964–1974

  37. 37.

    Leung YM, Kang YH, Gao XD, Xia FZ, Xie HL, Sheu L, Tsuk S, Lotan I, Tsushima RG, Gaisano HY (2003) Syntaxin 1A binds to the cytoplasmic C terminus of Kv2.1 to regulate channel gating and trafficking. J Biol Chem 278:17532–17538

  38. 38.

    Leung YM, Gao X, Sheu L, Tsuk S, Kang Y, Xie HL, Jones OT, Lotan I, Tsushima R G, Gaisano HY (2003) Syntaxin-1A binds and regulates Kv2.1 at its C-terminus and reduces Kv2.1 surface expression. Biophys J 84:153A–153A

  39. 39.

    Saxena S, Quick MW, Tousson A, Oh Y, Warnock DG (1999) Interaction of syntaxins with the amiloride-sensitive epithelial sodium channel. J Biol Chem 274:20812–20817

  40. 40.

    Condliffe SB, Carattino MD, Frizzell RA, Zhang H (2003) Syntaxin 1A regulates ENaC via domain-specific interactions. J Biol Chem 278:12796–12804

  41. 41.

    Condliffe S, Zhang H, Frizzell RA (2003) Acute inhibition of ENaC function by syntaxin 1A. FASEB J 17:A914–A914

  42. 42.

    Naren AP, Nelson DJ, Xie WW, Jovov B, Pevsner J, Bennett MK, Benos DJ, Quick MW, Kirk KL (1997) Regulation of CFTR chloride channels by syntaxin and Munc18 isoforms. Nature 390:302–305

  43. 43.

    Sugiyama T, Furuya A, Monkawa T, Yamamoto-Hino M, Satoh S, Ohmori K, Miyawaki A, Hanai N, Mikoshiba K, Hasegawa M (1994) Monoclonal antibodies distinctively recognizing the subtypes of inositol 1, 4, 5-trisphosphate receptor: application to the studies on inflammatory cells. FEBS Lett 354:149–154

  44. 44.

    Nakayama T, Hattori M, Uchida K, Nakamura T, Tateishi Y, Bannai H, Iwai M, Michikawa T, Inoue T, Mikoshiba K (2004) The regulatory domain of the inositol 1, 4, 5-trisphosphate receptor is necessary to keep the channel domain closed: possible physiological significance of specific cleavage by caspase 3. Biochem J 377:299–307

  45. 45.

    Lupas A, Van Dyke M, Stock J (1991) Predicting coiled coils from protein sequences. Science 252:1162–1164

  46. 46.

    Misura KM, Scheller RH, Weis WI (2000) Three-dimensional structure of the neuronal-Sec1-syntaxin 1a complex. Nature 404:355–362

  47. 47.

    Johenning FW, Zochowski M, Conway SJ, Holmes AB, Koulen P, Ehrlich BE (2002) Distinct intracellular calcium transients in neurites and somata integrate neuronal signals. J Neurosci 22:5344–5353

  48. 48.

    Haynes LP, Tepikin AV, Burgoyne RD (2004) Calcium-binding protein 1 is an inhibitor of agonist-evoked, inositol 1, 4, 5-trisphosphate-mediated calcium signaling. J Biol Chem 279:547–555

  49. 49.

    Hur EM, Park YS, Huh YH, Yoo SH, Woo KC, Choi BH, Kim KT (2005) Junctional membrane inositol 1, 4, 5-trisphosphate receptor complex coordinates sensitization of the silent EGF-induced Ca2+ signaling. J Cell Biol 169:657–667

  50. 50.

    Zhang Z, Hui E, Chapman ER, Jackson MB (2009) Phosphatidylserine regulation of Ca2+-triggered exocytosis and fusion pores in PC12 cells. Mol Biol Cell 20:5086–5095

  51. 51.

    Zhang S, Mizutani A, Hisatsune C, Higo T, Bannai H, Nakayama T, Hattori M, Mikoshiba K (2003) Protein 4.1 N is required for translocation of inositol 1, 4, 5-trisphosphate receptor type 1 to the basolateral membrane domain in polarized Madin–Darby canine kidney cells. J Biol Chem 278:4048–4056

  52. 52.

    Maeda N, Kawasaki T, Nakade S, Yokota N, Taguchi T, Kasai M, Mikoshiba K (1991) Structural and functional characterization of inositol 1, 4, 5-trisphosphate receptor channel from mouse cerebellum. J Biol Chem 266:1109–1116

  53. 53.

    Yamada M, Miyawaki A, Saito K, Nakajima T, Yamamoto-Hino M, Ryo Y, Furuichi T, Mikoshiba K (1995) The calmodulin-binding domain in the mouse type 1 inositol 1, 4, 5-trisphosphate receptor. Biochem J 308(1):83–88

  54. 54.

    Chen YA, Scheller RH (2001) Snare-mediated membrane fusion. Nat Rev Mol Cell Bio 2:98–106

  55. 55.

    Catterall WA (1999) Interactions of presynaptic Ca2+ channels and snare proteins in neurotransmitter release. Ann N Y Acad Sci 868:144–159

  56. 56.

    Koh S, Yamamoto A, Inoue A, Inoue Y, Akagawa K, Kawamura Y, Kawamoto K, Tashiro Y (1993) Immunoelectron microscopic localization of the HPC-1 antigen in rat cerebellum. J Neurocytol 22:995–1005

  57. 57.

    Tagaya M, Toyonaga S, Takahashi M, Yamamoto A, Fujiwara T, Akagawa K, Moriyama Y, Mizushima S (1995) Syntaxin 1 (HPC-1) is associated with chromaffin granules. J Biol Chem 270:15930–15933

  58. 58.

    Foletti DL, Lin R, Finley MA, Scheller RH (2000) Phosphorylated syntaxin 1 is localized to discrete domains along a subset of axons. J Neurosci 20:4535–454458

  59. 59.

    Yoshioka M, Yamazaki Y, Fujii S, Kaneko K, Kato H, Mikoshiba K (2010) Intracellular calcium ion dynamics involved in long-term potentiation in hippocampal CA1 neurons in mice lacking the IP3 type 1 receptor. Neurosci Res 67:149–155

Download references


We thank Dr. Hideaki Ando for help with the preparation of recombinant GST-fused proteins. We are grateful to the Support Unit for Bio-material Analysis, RIKEN BSI Research Resources Center, for help with DNA sequencing analysis and purification of anti-Syx1B. This study was supported by grants from ICORP and SORST (to K.M.) and in part by a Grant-in-Aid for Young Scientists (B) (to H.K.) and in part by a Grant-in-Aid for JSPS Fellows (to S.T) from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT).

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Correspondence to Hiroyuki Kabayama or Katsuhiko Mikoshiba.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Tanaka, S., Kabayama, H., Enomoto, M. et al. Inositol 1, 4, 5-trisphosphate receptor interacts with the SNARE domain of syntaxin 1B. J Physiol Sci 61, 221 (2011).

Download citation


  • Syntaxin 1B
  • SNARE domain
  • Inositol 1, 4, 5-trisphosphate receptor
  • Internal coupling domain